MTOR and COVID-19: Noteworthy, another rationale (Terrazzano et al., 2020) for using mTOR inhibitors in therapy for COVID-19 is derived from the original field of their medical application, which is the prevention of allotransplant rejection by inhibiting immune responses against foreign antigens.